Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
Announcing Winners of  Seventh Annual Regulatory Science Talent Competition

Announcing Winners of Seventh Annual Regulatory Science Talent Competition

The seventh annual America’s Got Regulatory Science Talent student competition was held on February 12, 2020. This year's winners proposed innovative solutions to regulatory science challenges in food safety, quality practices in medical product manufacturing, and informing the public of prescription drug risks and benefits. 

Announcing  the Winners of the America's Got Regulatory Science Talent Student Competition

Announcing the Winners of the America's Got Regulatory Science Talent Student Competition

The sixth annual America’s Got Regulatory Science Talent student competition featured presentations from twelve teams. Proposals ranged from a new policy to govern data sharing by medical/wearable devices to a farm-to-table produce-tracking app. Learn more about the competition and winners.

The Promises and Pitfalls of Omics in Precision Medicine

The Promises and Pitfalls of Omics in Precision Medicine

Omics techniques that rapidly analyze large amounts of genomic and other data from an individual cell, tissue or patient could greatly benefit precision medicine, but not without challenges. A UR CTSI-led team explored how to apply these techniques to precision medicine and revolutionize patient diagnosis and therapeutic interventions.

We Can Grow a New Ear, But How Do We Regulate It?

We Can Grow a New Ear, But How Do We Regulate It?

Technologies like 3D printing hold a lot of promise for precision medicine - even allowing scientists to grow new ears for children. As these technologies quickly advance, so does the need to regulate them. Regulatory scientists at the UR CTSI have led an effort to identify and address regulatory issues around these technologies so they can be safely applied to precision medicine.  

UR CTSI Joins Effort to Expand Experimental Treatment Access to Desperately Ill Patients

UR CTSI Joins Effort to Expand Experimental Treatment Access to Desperately Ill Patients

The University of Rochester Clinical and Translational Science Institute (UR CTSI) is part of a national effort to help hospitals offer experimental treatments to patients via the FDA’s Expanded Access process and improve how data is tracked from these patients.

1234